Erythroderma: A clinical, etiological and histopathological study at a tertiary care hospital in Karnataka
Journal Title: IP Indian Journal of Clinical and Experimental Dermatology - Year 2017, Vol 3, Issue 3
Abstract
Erythroderma was described by Hebra in 1868 as a generalised redness of skin. It manifests as extensive erythema and scaling over the body, classically >90% of body surface area. The incidence was estimated by Hasan and Jansen as 1-2 per 100,000 patients. Sehgal and Strivasta reported the incidence from India as 35 per 100,000 dermatologic outpatients. It may be due to a pre-existing dermatosis, drug induced reaction, malignancy and miscellaneous or idiopathic disorder. Among malignancies, lymphomas, including T-cell lymphomas like mycosis fungoides and sezary syndrome are commonly implicated. Skin biopsy is one of the cornerstones of the diagnostic investigations. However, in the setting of erythroderma, the histopathological changes are more subtle and hence difficult to interpret.
Authors and Affiliations
Neetha Thomas, Banavasi S. Girisha
Keywords
Related Articles
- EP ID EP300843
- DOI 10.18231/2455-6769.2017.0029
- Views 115
- Downloads 0
Treatment Pattern of dermatophytosis at the outpatient clinic of a tertiary healthcare hospital of Chhattisgarh, Central India
Background in the recent past dermatophytosis are being highly prevalent main culprit behind is inappropriate use of antifungal agents and selfmedications which is leading to exponential rise in global burden superficial...
Imatinib mesylate induced erythroderma: A rare case report
Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly rep...
Comparison of two modalities of phototherapy, narrowband UV-B and PUVA in the treatment of psoriasis: A study from Western Uttar Pradesh
Introduction PUVA psoralen UVA has been used since long time ago in psoriatic patients which has some adverse effects Phototherapy in form of Narrowband UVB is advancement in the treatment of psoriasis and it has been f...
Vitiligo following intravitreal ranibizumab: An association or an unrelated event?
Age-related macular degeneration (ARMD) is the most common cause for visual impairment in the elderly in western countries. Its incidence in India is expected to increase with the increase in the size of geriatric popula...
The prevalence of metabolic syndrome in patient with psoriasis
Introduction Psoriasis is a chronic relapsing remitting skin disease with T cell mediated inflammatory response The presence of increased no of proinflammatory cytokines leads to increase the risk of development of metab...